Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques.

Keywords

Quinolinic acid, Kynurenine, Kynurenine pathway, Encephalitis, Macaque

References

• Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptideJosé Manuel Azcona Pastor — 1988
• Cerebrospinal Fluid Nitrite/Nitrate Levels in Neurologic DiseasesOwen McLaughlin — 1994
• Neuroinvasion by simian immunodeficiency virus coincides with increased numbers of perivascular macrophages/microglia and intrathecal immune activation.Joan H. Lane, Vito G. Sasseville, Mary O. Smith — 1996
• Quinolinic acid and neurodegeneration in AIDS.郑煜 — 1995
• Stable isotope-labeled tryptophan as a precursor for studying the disposition of quinolinic acid in rabbits.Riccardo L. Boni, Melvyn P. Heyes, Johannes Bacher — 1991
• Quinolinic acid in neurological disease: opportunities for novel drug discovery.John F. Reinhard, Joel B. Erickson, Ellen M. Flanagan — 1994
• 4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-gamma-stimulated monocytes (THP-1 cells).Kuniaki Saito, C Y Chen, Monica I. Masana — 1993
• A mechanism for increased quinolinic acid formation following acute systemic immune stimulation.Kuniaki Saito, Jeffrey S. Crowley, Sanford P. Markey — 1993
• Study of Receptor-Mediated Neurotoxins Released by HIV-1-Infected Mononuclear Phagocytes Found in Human BrainDana Giulian, Jiahan Yu, Xia Li — 1996
• Poliovirus induces indoleamine‐2,3‐dioxygenase and quinolinic acid synthesis in macaque brainMelvyn P. Heyes, Kuniaki Saito, David M. Jacobowitz — 1992
• Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types.Melvyn P. Heyes, Cai Y. Chen, Eugene O. Major — 1997
• Human microglia convert l-tryptophan into the neurotoxin quinolinic acid.Melvyn P. Heyes, Kuniaki Saito, Sanford P. Markey — 1992
• Relationship between interferon‐γ, indoleamine 2,3‐dioxygenase, and tryptophan catabolismMilton W. Taylor, Gen‐Sheng Feng — 1991
• Neuropharmacology of quinolinic and kynurenic acids.Trevor W. Stone — 1993
• Cytopathologic and Neurochemical Correlates of Progression to Motor/Cognitive Impairment in SIV-lnfected Rhesus MonkeysDianne M. Rausch, Melviyn P. Heyes, Elisabeth A. Murray — 1994
• A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.Melvyn P. Heyes, Kuniaki Saito, Eugene O. Major — 1993
• Neuropeptides in the sympathetic system: Presence, plasticity, modulation, and implicationsEduardo E. Benarroch — 1994
• Human immunodeficiency virus type 1–infected monocytic cells can destroy human neural cells after cell‐to‐cell adhesionMarc Tardieu, Christiane Héry, Sylviane Peudenier — 1992
• Immunologic NO Synthase: Elevation in Severe AIDS Dementia and Induction by HIV-1 gp41D. Cory Adamson, Brigitte Wildemann, Masayuki Sasaki — 1996
• Kynurenine 3-hydroxylase in brain: species activity differences and effect of gerbil cerebral ischemia.Kuniaki Saito, Bonnie J. Quearry, Misato Saito — 1993

Cited by

• The mechanisms of neuronal damage in retroviral infections of the nervous system.Virginia Sanders, Clayton A. Wiley, Ronald L. Hamilton — 2001
• Excitotoxic degeneration of hypothalamic orexin neurons in slice culture.Arturo Familiar Sánchez — 2004
• Cellular interplay between neurons and glia: toward a comprehensive mechanism for excitotoxic neuronal loss in neurodegeneration.A. J. Markowitz, Michael G. White, Dennis L. Kolson — 2007
• 5 Kynurenines in the Brain: Preclinical and Clinical Studies, Therapeutic ConsiderationsCsaba Kiss, L. Vécsei — 2009
• Kynurenine metabolism in central nervous system in experimental chronic renal failure.J. Topczewska-Bruns, Dariusz Pawlak, Anna Tankiewicz‐Kwedlo — 2003
• RELATIONSHIP BETWEEN SYSTEMIC AND CENTRAL NERVOUS SYSTEM MONOCYTE/MACROPHAGE INFECTION IN SIMIAN IMMUNODEFICIENCY VIRUS ENCEPHALITISStephanie J. Bissel — 2006
• Immunologische Aspekte bei depressiven StörungenNorbert Müller, Markus Schwarz — 2007
• The Mechanisms of Neuronal Damage in Virus Infections of the Nervous SystemGeorg Gosztonyi — 2010
• Kynurenines in neurodegenerative disorders: therapeutic consideration.Péter Klivènyi, József Toldi, László Vécsei — 2004
• A psychoneuroimmunological perspective to Emil Kraepelins dichotomyNorbert Müller, Markus Schwarz — 2008
• Studies on experimental neonatal CNS infection : Implications for neuropsychiatric disordersLinnéa Asp — 2009
• Antioxidants Inhibit Indoleamine 2,3-Dioxygenase in IFN-γ-Activated Human Macrophages: Posttranslational Regulation by Pyrrolidine Dithiocarbamate1Shane R. Thomas, Houta Salahifar, Ryuichi Mashima — 2001
• An investigation of neurochemical, structural and functional characteristics in the murine model of collagen induced arthritisK. Mulloy — 2011
• Efeito in vitro de quinureninas sobre vários parâmetros de estresse oxidativo em córtex cerebral de ratos jovensGuilhian Leipnitz — 2006
• Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protectionGilles J. Guillemin, Stephen J. Kerr, George A. Smythe — 2001
• Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the l‐kynurenine and quinolinic acid pools in brainTomoyuki Kita, Paul F. Morrison, Melvyn P. Heyes — 2002
• The role of kynurenines in the production of neuronal death, and the neuroprotective effect of purinesTrevor W. Stone, W. M. H. Behan, Paul A. Jones — 2001
• Kynurenine Pathway Metabolites in Humans: Disease and Healthy StatesYiquan Chen, Gilles J. Guillemin — 2009
• Dysregulation of the kynurenine pathway in psychotic disorders : immunological aspectsMagdalena E. Kegel — 2014
• Dysregulation of tryptophan metabolism in a sub-Saharan HIV/AIDS populationPriyesh Bipath — 2015

Related papers

• Central kynurenine pathway shift with age in womenJosien de Bie, Jade Guest, Gilles J. Guillemin — 2016
• Modulation of Enzyme Activity in the Kynurenine Pathway by Kynurenine Monooxygenase InhibitionRobert S. Phillips, Emma Carine Iradukunda, Tamera D. Hughes — 2019
• The Kynurenine pathway in pancreatic carcinomaC. Blesl, A. Tmava, Andreas Baranyi — 2017
• Cytokine and drug modulation of kynurenine pathway metabolism by blood mononuclear cells.Kuniaki Saito, M Seishima, Akio Noma — 1996
• Hypothesis kynurenic and quinolinic acids: The main players of the kynurenine pathway and opponents in inflammatory disease.Abdulla A.‐B. Badawy — 2018
• S97. Celecoxib Augmentation of Escitalopram in Treatment-Resistant Bipolar Depression and the Effects on Quinolinic Acid in the Kynurenine PathwayMonica Feliz R. Castillo, Stephen Murata, Markus Schwarz — 2019
• Cerebral cortex and lung indoleamine-2,3-dioxygenase activity is increased in type-D retrovirus infected macaques.Kuniaki Saito, Andrew A. Lackner, Sanford P. Markey — 1991
• Elevated quinolinic acid levels in cerebrospinal fluid in subacute sclerosing panencephalitis.Hirofumi Inoue, Takeshi Matsushige, Takashi Ichiyama — 2019
• Galantamine-Memantine Combination and Kynurenine Pathway Enzyme Inhibitors in the Treatment of Neuropsychiatric DisordersMichael Y. Bai, David B. Lovejoy, Gilles J. Guillemin — 2021
• Characterization of the Kynurenine Pathway and Quinolinic Acid Production in Macaque MacrophagesChai K. Lim, Margaret Mei Chan Yap, Stephen J. Kent — 2013